EGFR and lung adenocarcinoma: Notably, however, we did not observe any associations with other traits for SFTPB, EGFR, and GAS1, which were associated with a lower risk of lung adenocarcinoma and a higher risk of breast cancer overall and triple-negative breast cancer, respectively.